AU2002217010A1 - Peptides, the production and use thereof for binding immunoglobulins - Google Patents
Peptides, the production and use thereof for binding immunoglobulinsInfo
- Publication number
- AU2002217010A1 AU2002217010A1 AU2002217010A AU1701002A AU2002217010A1 AU 2002217010 A1 AU2002217010 A1 AU 2002217010A1 AU 2002217010 A AU2002217010 A AU 2002217010A AU 1701002 A AU1701002 A AU 1701002A AU 2002217010 A1 AU2002217010 A1 AU 2002217010A1
- Authority
- AU
- Australia
- Prior art keywords
- peptides
- production
- binding immunoglobulins
- immunoglobulins
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Abstract
Peptides having the following amino acid sequence as well as peptides or proteins which contain this amino acid seque
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00124418.5 | 2000-11-08 | ||
EP00124418 | 2000-11-08 | ||
PCT/EP2001/012933 WO2002038592A2 (en) | 2000-11-08 | 2001-11-08 | Peptides, the production and use thereof for binding immunoglobulins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002217010A1 true AU2002217010A1 (en) | 2002-05-21 |
Family
ID=8170325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002217010A Abandoned AU2002217010A1 (en) | 2000-11-08 | 2001-11-08 | Peptides, the production and use thereof for binding immunoglobulins |
Country Status (7)
Country | Link |
---|---|
US (1) | US7205382B2 (en) |
EP (1) | EP1332158B1 (en) |
AT (1) | ATE368688T1 (en) |
AU (1) | AU2002217010A1 (en) |
DE (1) | DE50112802D1 (en) |
ES (1) | ES2292638T3 (en) |
WO (1) | WO2002038592A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6916904B2 (en) | 2002-04-24 | 2005-07-12 | Zolaris Biosciences, Llc | Inhibition of immune complex formation |
CA2497254A1 (en) | 2002-09-06 | 2004-03-18 | Forschungsverbund Berlin E. V. | Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
EP1730170B1 (en) | 2004-03-10 | 2020-02-19 | Trinity Therapeutics, Inc. | Method for inhibiting immune complex formation in a subject |
EP1754715A1 (en) | 2005-08-19 | 2007-02-21 | Bundesrepublik Deutschland vertreten durch das Bundesminsterium für Gesundheit, dieses vertr. durch das Robert-Koch-Institut | Vaccine on the basis of virus-neutralising antibodies |
US20080207498A1 (en) * | 2005-09-06 | 2008-08-28 | Bodie Neil M | Methods for Treating Alzheimer's Disease |
EP1832600A1 (en) | 2006-03-09 | 2007-09-12 | Max-Delbrück-Centrum Für Molekulare Medizin | Peptides against autoantibodies associated with glaucoma and use of these peptides |
GB0620200D0 (en) * | 2006-10-11 | 2006-11-22 | E2V Biosensors Ltd | Conjugates for use in analyte detection |
DE102007004909A1 (en) | 2007-01-26 | 2008-07-31 | Ga Generic Assays Gmbh | Use of pancreatic zymogen granule polypeptide GP2 as a medicament, especially for treating autoimmune diseases by plasmapheresis |
EP2080519A1 (en) * | 2008-01-15 | 2009-07-22 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor |
WO2010009380A2 (en) * | 2008-07-18 | 2010-01-21 | Trinity Therapeutics, Inc. | Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
EP2172481B1 (en) | 2008-10-06 | 2014-10-29 | Novoplant GmbH | Proteolytically stable antibody formats |
EP2199305A1 (en) | 2008-12-18 | 2010-06-23 | Max-Delbrück-Centrum | Peptides against autoantibodies associated with CRPS and use of these peptides |
AU2010285265B2 (en) | 2009-08-19 | 2015-05-21 | Merck Patent Gmbh | Antibodies for the detection of integrin complexes in FFPE material |
RU2014104690A (en) | 2011-08-12 | 2015-09-20 | Е.Р.Д.Е.-ААК-Диагностик ГмбХ | Agonistic autoantibodies to α1- and β2-adrenergic receptors in Alzheimer's disease and vascular dementia |
CN103890174B (en) * | 2011-08-24 | 2015-12-23 | 大塚化学株式会社 | IgG binding peptide and utilize it to detect and the method for IgG purification |
EP2913675B1 (en) | 2014-02-28 | 2020-02-12 | GA Generic Assays GmbH | GP2 isoforms and their use in autoantibody capture |
RU2760005C2 (en) | 2014-03-13 | 2021-11-22 | Университет Базель | CARBOHYDRATE LIGANDS THAT BIND TO IgM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN |
US11091591B2 (en) | 2015-09-16 | 2021-08-17 | Universität Basel | Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids |
KR102139057B1 (en) | 2015-10-23 | 2020-07-29 | 후지필름 가부시키가이샤 | Cyclic peptides, affinity chromatography carriers, labeled antibodies, antibody drug complexes, and pharmaceutical preparations |
WO2017069269A1 (en) * | 2015-10-23 | 2017-04-27 | 富士フイルム株式会社 | Cyclic peptide, affinity chromatography support, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation |
WO2017209471A1 (en) * | 2016-05-30 | 2017-12-07 | 동국대학교 산학협력단 | Affinity ligand for antibody purification, having high antibody binding capacity and mild elution condition, and use thereof |
EP3299818B1 (en) | 2016-09-26 | 2019-12-04 | GA Generic Assays GmbH | Method for the diagnosis of acute pancreatitis (ap) by detection of glycoprotein 2 isoform alpha (gp2a) |
WO2018061509A1 (en) | 2016-09-30 | 2018-04-05 | 富士フイルム株式会社 | Cyclic peptide, affinity chromatography carrier, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation |
WO2019015814A1 (en) | 2017-07-20 | 2019-01-24 | Ga Generic Assays Gmbh | Chitinase-3-like protein 1 (chi3l1) as an autoantigen in autoimmune disorders of the digestive system |
EP3669888A1 (en) | 2018-12-20 | 2020-06-24 | Gambro Lundia AB | Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies |
WO2020127968A1 (en) | 2018-12-20 | 2020-06-25 | Marino Stephen F | Protein-drug conjugate comprising a monomeric form of proteinase 3 |
WO2021018758A1 (en) | 2019-07-26 | 2021-02-04 | Technische Universität Dresden | Device for extracorporeal lowering of asymmetric dimethylarginine and monomethyl arginine levels in human blood |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1086955A1 (en) | 1999-09-21 | 2001-03-28 | Affina Immuntechnik GmbH | Peptides against antibodies elicited by DCM |
PT1240337E (en) * | 1999-12-24 | 2007-01-31 | Genentech Inc | Methods and compositions for prolonging elimination half-times of bioactive compounds |
-
2001
- 2001-11-08 EP EP01993614A patent/EP1332158B1/en not_active Expired - Lifetime
- 2001-11-08 DE DE50112802T patent/DE50112802D1/en not_active Expired - Lifetime
- 2001-11-08 US US10/415,665 patent/US7205382B2/en not_active Expired - Lifetime
- 2001-11-08 ES ES01993614T patent/ES2292638T3/en not_active Expired - Lifetime
- 2001-11-08 AT AT01993614T patent/ATE368688T1/en not_active IP Right Cessation
- 2001-11-08 WO PCT/EP2001/012933 patent/WO2002038592A2/en active IP Right Grant
- 2001-11-08 AU AU2002217010A patent/AU2002217010A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002038592A2 (en) | 2002-05-16 |
EP1332158B1 (en) | 2007-08-01 |
DE50112802D1 (en) | 2007-09-13 |
WO2002038592A3 (en) | 2003-01-23 |
US7205382B2 (en) | 2007-04-17 |
EP1332158A2 (en) | 2003-08-06 |
ATE368688T1 (en) | 2007-08-15 |
ES2292638T3 (en) | 2008-03-16 |
US20040087765A1 (en) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
WO2003011115A3 (en) | Peptide-based multimeric targeted contrast agents | |
AU2002360331A1 (en) | Egviii endoglucanase and nucleic acids encoding the same | |
WO2003052054A3 (en) | Bgl5 beta-glucosidase and nucleic acids encoding the same | |
WO2003027306A3 (en) | Bgl3 beta-glucosidase and nucleic acids encoding the same | |
EP2322552A3 (en) | IL-1beta binding antibodies and fragments thereof | |
WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
WO2003074546A3 (en) | Streptavidin-binding peptide | |
CA2361987A1 (en) | Goodpasture antigen binding protein | |
WO2006127822A3 (en) | Scytovirin domain 1 related polypeptides | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
AUPP627498A0 (en) | Novel peptides - i | |
MXPA04002103A (en) | A caspase- 8 binding protein, its preparation and use. | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
WO2001002429A3 (en) | Angiopoietin-6 and uses thereof | |
EP0816498A3 (en) | Excitatory amino acid receptor protein and related nucleic acid compounds | |
WO2001092468A3 (en) | Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof | |
AU2003295435A1 (en) | Biological carriers for the delivery of proteins or peptides | |
WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
WO2002088168A3 (en) | Codon-optimised nucleic acid coding for apoaequorin and uses thereof | |
AU2002365925A1 (en) | Rsv proteins, antibodies, compositions, methods and uses | |
WO2000042063A3 (en) | Peptides for inhibiting hbv core proteins | |
AU759012C (en) | Amino acid sequence |